Baxter International BAX Pharmaceuticals — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's pharmaceuticals — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's pharmaceuticals — goodwill?
- Baxter International (BAX) reported pharmaceuticals — goodwill of $569M in Q1 2026.
- How has Baxter International's pharmaceuticals — goodwill changed year-over-year?
- Baxter International's pharmaceuticals — goodwill increased by 2.2% year-over-year, from $557M to $569M.
- What does pharmaceuticals — goodwill mean?
- The excess purchase price paid for the Pharmaceuticals business segment over the fair value of its net assets.
- How do you interpret pharmaceuticals — goodwill?
- An increase typically reflects recent acquisitions, while a decrease suggests impairment charges or divestitures.
- How does pharmaceuticals — goodwill compare across companies?
- Common in companies that grow through M&A; peers in the medical device and pharma space often carry significant goodwill balances.